Part Number : NDC52544-0372-01 | Manufacturer : Watson Labs Inc | ||
NSN : 6505-01-190-6285 (6505011906285) | |||
Item Name : Loxapine Capsules Usp | CAGE Code : 0BN85 | ||
NIIN : 01-190-6285 (011906285) | |||
INC Code : 49896 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC52544037201 |
Thank you for taking an interest in part number NDC52544-0372-01, that of which is listed with the description Loxapine Capsules Usp; Manufactured by Watson Labs Inc and listed alongside the NSN 6505011906285, part number NDC52544-0372-01 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC52544-0372-01 | Manufacturer : Watson Labs Inc | ||
NSN Number : 6505-01-190-6285 (6505011906285) | |||
Item Name : Loxapine Capsules Usp | CAGE Code : 0BN85 | ||
NIIN : 011906285 |
Thank you for taking an interest in part number NDC52544-0372-01, that of which is listed with the description Loxapine Capsules Usp; Manufactured by Watson Labs Inc and listed alongside the NSN 6505011906285, part number NDC52544-0372-01 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-190-6285 Item Description: Loxapine Capsules Usp | 6505 | 011906285 | Q | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc52544-0372-01 | 2 | 9 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
CXCY | Part Name Assigned By Controlling Agency | LOXAPINE CAPSULES USP 50MG 100S BT |
CYLZ | Capsule Primary Container Content Quantity | 100 |
MRC | Decoded Requirement | Clear Text Reply |
AKJA | Active Medicament Medicinal Strength | 50.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT |
CQCT | Primary Container Type | BOTTLE |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote